help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruggles, B. T.
Right arrow Articles by Dousa, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruggles, B. T.
Right arrow Articles by Dousa, T. P.

Journal of Clinical Endocrinology & Metabolism, Vol 60, 914-921, Copyright © 1985 by Endocrine Society


ARTICLES

The vasopressin-sensitive adenylate cyclase in collecting tubules and in thick ascending limb of Henle's loop of human and canine kidney

BT Ruggles, N Murayama, JL Werness, SM Gapstur, MD Bentley and TP Dousa

The major tubular effects of [8-Arg]vasopressin (AVP) in regulation of renal water excretion are initiated by stimulation of adenylate cyclase (AdC) coupled with V2 receptors. We explored whether the AVP-sensitive AdC is present in both collecting tubules and the thick ascending limb of Henle's loop of human and canine kidney. In cortical collecting tubule (CCT) and medullary collecting tubules (MCT) of human kidney, AdC was markedly stimulated by AVP [maximum change from basal level (delta), +2700%] and the the nonhormonal stimulatory agent forskolin (delta, +2000%). In human CCT, the effects of both compounds were synergistic. In contrast, AVP had no effect on AdC in either the medullary (MAL) or cortical (CAL) segment of the thick ascending limb of Henle's loop of human kidney; AVP also did not stimulate AdC in CAL or MAL in the presence of forskolin. Similar to that in the human kidney, in the canine kidney, AdC in CCT and MCT was markedly stimulated by AVP and forskolin (delta, +1000%), but AVP had no effect on AdC in CAL and MAL of the canine kidney. In intact tubules dissected from dog kidney and incubated in vitro, AVP markedly increased cAMP accumulation in MCT. AVP also elicited a small but detectable increase in cAMP accumulation in MAL. From these observations, we conclude that AVP-sensitive AdC is well developed in collecting tubules, but that AVP- sensitive AdC is absent in MAL and CAL of human kidney. Likewise, in canine nephron, the AVP-sensitive AdC of MAL and CAL is rudimentary or very labile. These findings suggest that the unresponsiveness of the AdC-cAMP system to AVP in segments of the thick ascending limb of Henle's loop may be a factor that accounts for a relatively low maximum osmotic concentration of urine which can be achieved by human or canine kidneys.


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Rieg, K. Pothula, J. Schroth, J. Satriano, H. Osswald, J. Schnermann, P. A. Insel, R. A. Bundey, and V. Vallon
Vasopressin regulation of inner medullary collecting ducts and compensatory changes in mice lacking adenosine A1 receptors
Am J Physiol Renal Physiol, March 1, 2008; 294(3): F638 - F644.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. Bankir, S. Fernandes, P. Bardoux, N. Bouby, and D. G. Bichet
Vasopressin-V2 Receptor Stimulation Reduces Sodium Excretion in Healthy Humans
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 1920 - 1928.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Acharjee, J.-L. Do-Rego, D. Y. Oh, R. S. Ahn, H. Choe, H. Vaudry, K. Kim, J. Y. Seong, and H. B. Kwon
Identification of Amino Acid Residues That Direct Differential Ligand Selectivity of Mammalian and Nonmammalian V1a Type Receptors for Arginine Vasopressin and Vasotocin: INSIGHTS INTO MOLECULAR COEVOLUTION OF V1a TYPE RECEPTORS AND THEIR LIGANDS
J. Biol. Chem., December 24, 2004; 279(52): 54445 - 54453.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Gimenez and B. Forbush
Short-term Stimulation of the Renal Na-K-Cl Cotransporter (NKCC2) by Vasopressin Involves Phosphorylation and Membrane Translocation of the Protein
J. Biol. Chem., July 11, 2003; 278(29): 26946 - 26951.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Feraille and A. Doucet
Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control
Physiol Rev, January 1, 2001; 81(1): 345 - 418.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Hirano, Y. Yamamura, S. Nakamura, T. Onogawa, and T. Mori
Effects of the V2-Receptor Antagonist OPC-41061 and the Loop Diuretic Furosemide Alone and in Combination in Rats
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 288 - 294.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
M. A. KNEPPER, G.-H. KIM, P. FERNÁNDEZ-LLAMA, and C. A. ECELBARGER
Regulation of Thick Ascending Limb Transport by Vasopressin
J. Am. Soc. Nephrol., March 1, 1999; 10(3): 628 - 634.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society